Hubbell Capitalized research expenditures decreased by 42.2% to $32.50M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 42.2%, from $56.20M to $32.50M. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates higher R&D investment or changes in tax amortization schedules for innovation costs.
Deferred tax assets arising from the capitalization of research and development expenditures for tax purposes that diffe...
Common in industrial companies with heavy investment in product development and engineering.
other_deferred_tax_assets_tax_deferred_expense_capitaliz_3989a4| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $0.00 | $18.40M | $40.00M | $56.20M | $32.50M |
| QoQ Change | — | — | +117.4% | +40.5% | -42.2% |
| YoY Change | — | — | +117.4% | +40.5% | -42.2% |